We showed that serum levels of inflammatory mediators such as MMP-3 and blood mRNA expression of antioxidant enzymes superoxide dismutase (sod1) and catalase (cat) significantly correlated with pain scores in the human early RA cohort. The gene discussed is CAT; the disease is rheumatoid arthritis.